Literature DB >> 17670819

West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence.

Guido van Marle1, Joseph Antony, Heather Ostermann, Christopher Dunham, Tracey Hunt, William Halliday, Ferdinand Maingat, Matt D Urbanowski, Tom Hobman, James Peeling, Christopher Power.   

Abstract

West Nile virus (WNV) infection causes neurological disease at all levels of the neural axis, accompanied by neuroinflammation and neuronal loss, although the underlying mechanisms remain uncertain. Given the substantial activation of neuroinflammatory pathways observed in WNV infection, we hypothesized that WNV-mediated neuroinflammation and cell death occurred through WNV infection of both glia and neurons, which was driven in part by WNV capsid protein expression. Analysis of autopsied neural tissues from humans with WNV encephalomyelitis (WNVE) revealed WNV infection of both neurons and glia. Upregulation of proinflammatory genes, CXCL10, interleukin-1beta, and indolamine-2',3'-deoxygenase with concurrent suppression of the protective astrocyte-specific endoplasmic reticulum stress sensor gene, OASIS (for old astrocyte specifically induced substance), was evident in WNVE patients compared to non-WNVE controls. These findings were supported by increased ex vivo expression of these proinflammatory genes in glia infected by WNV-NY99. WNV infection caused endoplasmic reticulum stress gene induction and apoptosis in neurons but did not affect glial viability. WNV-infected astrocytic cells secreted cytotoxic factors, which caused neuronal apoptosis. The expression of the WNV-NY99 capsid protein in neurons and glia by a Sindbis virus-derived vector (SINrep5-WNVc) caused neuronal death and the release of neurotoxic factors by infected astrocytes, coupled with proinflammatory gene induction and suppression of OASIS. Striatal implantation of SINrep5-WNV(C) induced neuroinflammation in rats, together with the induction of CXCL10 and diminished OASIS expression, compared to controls. Moreover, magnetic resonance neuroimaging showed edema and tissue injury in the vicinity of the SINrep5-WNVc implantation site compared to controls, which was complemented by neurobehavioral abnormalities in the SINrep5-WNVc-implanted animals. These studies underscore the important interactions between the WNV capsid protein and neuroinflammation in the pathogenesis of WNV-induced neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17670819      PMCID: PMC2045515          DOI: 10.1128/JVI.02422-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

Review 1.  West Nile virus in the US and abroad.

Authors:  Richard T Johnson
Journal:  Curr Clin Top Infect Dis       Date:  2002

2.  Characterization of a 105-kDa plasma membrane associated glycoprotein that is involved in West Nile virus binding and infection.

Authors:  J J H Chu; M L Ng
Journal:  Virology       Date:  2003-08-01       Impact factor: 3.616

3.  Expression of OASIS, a CREB/ATF family transcription factor, in CNS lesion and its transcriptional activity.

Authors:  Takuya Nikaido; Ken Iseki; Tetsuji Mori; Hiromi Takaki; Sachihiko Yokoya; Seita Hagino; Junko Takeda; Yuxiang Zhang; Mayumi Takeuchi; Shin-ichi Kikuchi; Akio Wanaka
Journal:  Brain Res Mol Brain Res       Date:  2002-12

4.  Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis.

Authors:  Leonie A Boven; Nathalie Vergnolle; Scot D Henry; Claudia Silva; Yoshinori Imai; Janet Holden; Kenneth Warren; Morley D Hollenberg; Christopher Power
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

Review 5.  The molecular biology of West Nile Virus: a new invader of the western hemisphere.

Authors:  Margo A Brinton
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

6.  Human immunodeficiency virus type 1 envelope-mediated neuropathogenesis: targeted gene delivery by a Sindbis virus expression vector.

Authors:  Guido van Marle; Julie Ethier; Claudia Silva; Brian A Mac Vicar; Christopher Power
Journal:  Virology       Date:  2003-04-25       Impact factor: 3.616

7.  Response of neurons and microglia/macrophages in the area postrema of adult rats following exposure to hypobaric hypoxia.

Authors:  S S Al-Saleh; C Kaur; E A Ling
Journal:  Neurosci Lett       Date:  2003-07-31       Impact factor: 3.046

Review 8.  Molecular pathogenesis of neuroinflammation.

Authors:  M Bradl; R Hohlfeld
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

9.  Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo.

Authors:  Maria Laura Giustizieri; Cristina Albanesi; Claudia Scarponi; Ornella De Pità; Giampiero Girolomoni
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

10.  Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway.

Authors:  Joo-Sung Yang; Mathura P Ramanathan; Karuppiah Muthumani; Andrew Y Choo; Sung-Ha Jin; Qian-Chun Yu; Daniel S Hwang; Daniel K Choo; Mark D Lee; Kesen Dang; Waixing Tang; J Joseph Kim; David B Weiner
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more
  55 in total

1.  Uncoupling cis-Acting RNA elements from coding sequences revealed a requirement of the N-terminal region of dengue virus capsid protein in virus particle formation.

Authors:  Marcelo M Samsa; Juan A Mondotte; Julio J Caramelo; Andrea V Gamarnik
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Innate host responses to West Nile virus: Implications for central nervous system immunopathology.

Authors:  Giada Rossini; Maria Paola Landini; Francesco Gelsomino; Vittorio Sambri; Stefania Varani
Journal:  World J Virol       Date:  2013-05-12

3.  Induction of the cellular microRNA, Hs_154, by West Nile virus contributes to virus-mediated apoptosis through repression of antiapoptotic factors.

Authors:  Jessica L Smith; Finn E Grey; Jennifer L Uhrlaub; Janko Nikolich-Zugich; Alec J Hirsch
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

4.  Heterogeneous nuclear ribonucleoprotein A2 participates in the replication of Japanese encephalitis virus through an interaction with viral proteins and RNA.

Authors:  Hiroshi Katoh; Yoshio Mori; Hiroto Kambara; Takayuki Abe; Takasuke Fukuhara; Eiji Morita; Kohji Moriishi; Wataru Kamitani; Yoshiharu Matsuura
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

5.  RIG-I is required for VSV-induced cytokine production by murine glia and acts in combination with DAI to initiate responses to HSV-1.

Authors:  Emma K Crill; Samantha R Furr-Rogers; Ian Marriott
Journal:  Glia       Date:  2015-07-03       Impact factor: 7.452

6.  The membrane-bound transcription factor CREB3L1 is activated in response to virus infection to inhibit proliferation of virus-infected cells.

Authors:  Bray Denard; Joachim Seemann; Qiuyue Chen; Austin Gay; Hua Huang; Yan Chen; Jin Ye
Journal:  Cell Host Microbe       Date:  2011-07-21       Impact factor: 21.023

Review 7.  Roles of regulated intramembrane proteolysis in virus infection and antiviral immunity.

Authors:  Jin Ye
Journal:  Biochim Biophys Acta       Date:  2013-12

8.  Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death.

Authors:  Mukesh Kumar; Saguna Verma; Vivek R Nerurkar
Journal:  J Neuroinflammation       Date:  2010-10-31       Impact factor: 8.322

9.  Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor.

Authors:  Saguna Verma; Mukesh Kumar; Ulziijargal Gurjav; Stephanie Lum; Vivek R Nerurkar
Journal:  Virology       Date:  2009-11-18       Impact factor: 3.616

Review 10.  Properties and Functions of the Dengue Virus Capsid Protein.

Authors:  Laura A Byk; Andrea V Gamarnik
Journal:  Annu Rev Virol       Date:  2016-08-03       Impact factor: 10.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.